The modern psychedelic renaissance is often framed through the lens of clinical legitimacy. Today, psilocybin is being studied at world-leading...

LSD occupies a uniquely complicated position in the history of psychedelic medicine. Few compounds have had such an outsized influence...

The psychedelic medicine sector has entered its most important phase yet. The hype cycle is over. The speculative frenzy that...

Australian psychedelic-assisted therapy provider Emyria has reported encouraging early results from its treatment-resistant depression program, marking another important milestone for...

Compass Pathways has moved closer than any company in the psychedelic medicine sector to securing U.S. regulatory approval for a...

The psychedelic medicine sector has reached an important inflection point. After years of scientific breakthroughs, headline-grabbing clinical trial results and...

Australia's landmark clinical framework could shape how psychiatrists deliver psychedelic-assisted therapies around the world For years, psychedelic medicine has largely...

The psychedelic medicine sector has spent much of the past decade fighting for scientific credibility, regulatory acceptance, and investor confidence....

On June 20, thousands of people across the world marked World Psychedelics Day 2026, an annual global awareness initiative that...

Monash University researchers launch groundbreaking study exploring whether psychedelic-assisted therapy can help patients living with the long-term effects of brain...